These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30747326)

  • 1. Adverse Effects of Physostigmine.
    Arens AM; Kearney T
    J Med Toxicol; 2019 Jul; 15(3):184-191. PubMed ID: 30747326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose.
    Pentel P; Peterson CD
    Ann Emerg Med; 1980 Nov; 9(11):588-90. PubMed ID: 7001962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of physostigmine: a 10-year retrospective review.
    Arens AM; Shah K; Al-Abri S; Olson KR; Kearney T
    Clin Toxicol (Phila); 2018 Feb; 56(2):101-107. PubMed ID: 28703024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Resource Utilization in the Management of Anticholinergic Delirium Between Physostigmine and Nonantidote Therapy.
    Boley SP; Stellpflug SJ
    Ann Pharmacother; 2019 Oct; 53(10):1026-1032. PubMed ID: 31023063
    [No Abstract]   [Full Text] [Related]  

  • 5. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center.
    Boley SP; Olives TD; Bangh SA; Fahrner S; Cole JB
    Clin Toxicol (Phila); 2019 Jan; 57(1):50-55. PubMed ID: 29956570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physostigmine reversal of delirium from second generation antipsychotic exposure: a retrospective cohort study from a regional poison center.
    Arens AM; Sheikh Said H; Driver BE; Cole JB
    Clin Toxicol (Phila); 2024 Jul; 62(7):463-467. PubMed ID: 38984853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine: is there a role for this antidote in pediatric poisonings?
    Frascogna N
    Curr Opin Pediatr; 2007 Apr; 19(2):201-5. PubMed ID: 17496766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivastigmine for the management of anticholinergic delirium.
    Chiew AL; Holford AG; Chan BSH; Isoardi KZ
    Clin Toxicol (Phila); 2024 Feb; 62(2):82-87. PubMed ID: 38465631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
    Hail SL; Obafemi A; Kleinschmidt KC
    Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome.
    Wang GS; Baker K; Ng P; Janis GC; Leonard J; Mistry RD; Heard K
    Clin Toxicol (Phila); 2021 Aug; 59(8):698-704. PubMed ID: 33295809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physostigmine versus diazepines for anticholinergic poisoning.
    Oakley P
    Ann Emerg Med; 2001 Feb; 37(2):239-41. PubMed ID: 11174251
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological management of anticholinergic delirium - theory, evidence and practice.
    Dawson AH; Buckley NA
    Br J Clin Pharmacol; 2016 Mar; 81(3):516-24. PubMed ID: 26589572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.
    Phillips MA; Acquisto NM; Gorodetsky RM; Wiegand TJ
    J Med Toxicol; 2014 Jun; 10(2):205-9. PubMed ID: 24798647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Physostigmine as an antidote: use with caution.
    Mofenson HC; Greensher J
    J Pediatr; 1975 Dec; 87(6 Pt 1):1011-2. PubMed ID: 1185381
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse events from physostigmine: An observational study.
    Nguyen TT; Armengol C; Wilhoite G; Cumpston KL; Wills BK
    Am J Emerg Med; 2018 Jan; 36(1):141-142. PubMed ID: 28716594
    [No Abstract]   [Full Text] [Related]  

  • 16. Physostigmine in tricyclic antidepressant overdose.
    Johnson PB
    JACEP; 1976 Jun; 5(6):443-5. PubMed ID: 933413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
    Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
    J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physostigmine and anaesthesia emergence delirium in preschool children: a randomized blinded trial.
    Funk W; Hollnberger H; Geroldinger J
    Eur J Anaesthesiol; 2008 Jan; 25(1):37-42. PubMed ID: 17655781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication.
    Bania TC; Chu J
    Acad Emerg Med; 2005 Mar; 12(3):185-9. PubMed ID: 15741579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of diagnostic physostigmine administration to emergency department patients.
    Schneir AB; Offerman SR; Ly BT; Davis JM; Baldwin RT; Williams SR; Clark RF
    Ann Emerg Med; 2003 Jul; 42(1):14-9. PubMed ID: 12827117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.